Clinical trial
Local Excision in Downstaged Rectal Cancer
NCT00427375 · University Hospital, Bordeaux, Other · Completed
Key facts
| NCT number | NCT00427375 |
|---|---|
| Title | Local Excision in Downstaged Rectal Cancer |
| Official title | Phase III Randomized Trial of Local Excision Versus Total Mesorectal Excision in Downstaged T2T3 Low Rectal Cancer After Radiochemotherapy |
| Acronym | GRECCAR 2 |
| Lead sponsor | University Hospital, Bordeaux, Other |
| Collaborators | Sanofi Industry Roche Pharma AG |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rectal Neoplasms |
| Intervention type | Procedure |
| Interventions | local rectal excision, total mesorectal excision |
| Enrollment | 148 |
| Start date | Mar 5, 2007 |
| Primary completion | Dec 1, 2014 |
| Completion | Feb 8, 2018 |
| First posted | Jan 29, 2007 |
| Last update posted | Mar 14, 2018 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: